Federal Register - August 24, 2021
Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.
Source: Federal Register
Federal Register / Vol. 86, No. 161 / Tuesday, August 24, 2021 / Notices https www.effectivehealthcare.ahrq.
gov/email-updates.
The systematic review will answer the following questions. This information is provided as background. AHRQ is not requesting that the public provide answers to these questions.
Key Questions KQs KQ 1: What are the benefits and harms of different antenatal care schedules that vary by number or timing of visits for pregnancies requiring routine care and monitoring?
47311
KQ 2: What are the benefits and harms of telemedicine for providing routine antenatal care during pregnancy?
KQ 3: What are patient, partner/
family, and provider perspectives, preferences, and experiences related to antenatal care visit schedules and use of telemedicine for routine antenatal care?
PICOTS POPULATION, INTERVENTION, COMPARATOR, OUTCOME, TIMING, SETTING
Category
Definition
Population
KQ 1 & 2:
Pregnant individuals receiving routine/standard/basic/traditional antenatal care.
Allow studies of pregnant individuals at increased risk of poor outcomes e.g., with gestational diabetes, gestational hypertension, fetal growth restriction, those receiving part of their antenatal care by maternalfetal medicine MFM or other specialists, as long as the study pertains to their routine antenatal care i.e., not specifically to their enhanced care for their high-risk condition.
KQ3:
Pregnant individuals.
Postpartum individuals.
Individuals considering or planning pregnancy.
Partners/family.
Providers of antenatal care any profession or licensure.
Allow studies that include high-risk patients, as long as the interventions being assessed pertain to routine care.
KQ1:
Defined routine antenatal care schedules with focus on:
D Total number of planned visits.
D Overall schedule timing, frequency, cadence.
D Number of planned in-person visits.
Providers of routine antenatal visits include: Obstetricians/gynecologists, nurse practitioners, nurse midwives, nurses, physician assistants, family medicine clinicians.
Include interventions designed to evaluate different types of providers e.g., a nurse instead of a doctor if there is a concomitant comparison of different schedule of planned visits.
Include interventions designed to evaluate group visits if the group visits replace individual visits and there is a concomitant comparison of different schedule of planned visits.
Include interventions designed to evaluate home visits if the home visits replace in-clinic visits and there is a concomitant comparison of different schedule of planned visits.
KQ2:
Antenatal care programs using telemedicine, including remote synchronous real-time visits such as video calls and asynchronous interactions e.g., portal email discussions.
Allow inclusion of devices designed to transmit information only if use of the devices are part of telemedicine interactions between patients and providers.
KQ3:
Routine antenatal care, specific to interventions covered in KQ 1 and 2.
KQ1:
Standard, routine, or alternative antenatal care schedule as defined by the study.
KQ2:
All in-person care, alternative telemedicine/remote care.
No explicit comparator.
KQ3:
Not applicable.
KQ1 & KQ2:
Pregnancy complications:
D Maternal mortality.
D Antenatal pregnancy complications.
D Delivery-related complications.
Other maternal health outcomes:
D Delivery outcomes.
D Inappropriate weight gain.
D Postpartum contraceptionmust be adjusted to account for patient preferences.
Maternal psychosocial, preferences, and related outcomes:
D Quality of life measures.
D Psychosocial measures.
D Mental health measures or diagnosis e.g., anxiety, depression.
D Patient satisfaction with antenatal care.
D Patient preferences.
D Resources.
Fetal/neonatal/infant outcomes:
D Delivery timing.
D Mortality.
D Perinatal morbidity e.g., birth trauma.
Interventions
Comparators
lotter on DSK11XQN23PROD with NOTICES1
Outcomes prioritized have an asterisk.
VerDate Sep<11>2014
outcomes
16:43 Aug 23, 2021
Jkt 253001
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
E:FRFM24AUN1.SGM
24AUN1